Skip to Content
Merck
CN
  • Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

The Journal of neuroscience : the official journal of the Society for Neuroscience (2014-07-11)
Sarah Y Branch, Ramaswamy Sharma, Michael J Beckstead
ABSTRACT

Substantia nigra dopamine neurons are involved in behavioral processes that include cognition, reward learning, and voluntary movement. Selective deterioration of these neurons is responsible for the motor deficits associated with Parkinson's disease (PD). Aging is the leading risk factor for PD, suggesting that adaptations occurring in dopamine neurons during normal aging may predispose individuals to the development of PD. Previous studies suggest that the unique set of ion conductances that drive spontaneous, rhythmic firing of action potentials could predispose substantia nigra dopamine neurons to selective neurodegeneration. Here we show, using patch-clamp electrophysiological recordings in brain slices, that substantia nigra dopamine neurons from mice 25-30 months of age (old) have comparable membrane capacitance and input resistance to neurons from mice 2-7 months of age (young). However, neurons from old mice exhibit slower firing rates, narrower spike widths, and more variable interspike intervals compared with neurons from young mice. Dopamine neurons from old mice also exhibit smaller L-type calcium channel currents, providing a plausible mechanism that likely contributes to the changes in impulse activity. Age-related decrements in the physiological function of dopamine neurons could contribute to the decrease in voluntary movement and other dopamine-mediated behaviors observed in aging populations. Furthermore, as pharmacological antagonism of L-type calcium channels has been proposed as a potential treatment for the early stages of PD, our results could point to a limited temporal window of opportunity for this therapeutic intervention.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, BioUltra, ≥99.0% (T)
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, Molecular Biology, ≥97.0%
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, BioXtra, ≥97 .0%
Sigma-Aldrich
Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid, ≥97.0%
Sigma-Aldrich
2,2,2-Tribromoethanol, 97%
Sigma-Aldrich
Kynurenic acid, ≥98%
Sigma-Aldrich
Cesium chloride, 99.99% trace metals basis
Sigma-Aldrich
Cesium chloride, AnhydroBeads, −10 mesh, 99.999% trace metals basis
Sigma-Aldrich
DL-Tyrosine, 99%
Sigma-Aldrich
Cesium chloride, ≥99.999% trace metals basis
Sigma-Aldrich
Adenosine
Sigma-Aldrich
Apamin, synthetic, ≥97% (HPLC)
Sigma-Aldrich
DNQX, ≥98% (TLC)
Sigma-Aldrich
Hexamethonium chloride, solid (hygroscopic)
Sigma-Aldrich
Cesium chloride, Molecular Biology, ≥98%
Sigma-Aldrich
Cesium chloride, optical grade, ≥99.5% trace metals basis
Sigma-Aldrich
Adenosine, ≥99%
Sigma-Aldrich
Adenosine, BioReagent, suitable for cell culture
Sigma-Aldrich
Nimodipine
Sigma-Aldrich
Cesium chloride, Grade II, ≥98%
Sigma-Aldrich
Apamin, from bee venom, ≥95% (HPLC)
Sigma-Aldrich
Guanosine, ≥98%
Sigma-Aldrich
Cesium chloride, BioUltra, Molecular Biology, ≥99.5% (AT)
Sigma-Aldrich
Cesium chloride, Grade I, ≥99.0%
Sigma-Aldrich
Cesium chloride, Molecular Biology, ≥99% (silver nitrate titration)
Sigma-Aldrich
Cesium chloride, BioXtra, ≥99.5% (titration)
Sigma-Aldrich
Cadmium chloride, 99.99% trace metals basis
Sigma-Aldrich
Guanosine, BioReagent, suitable for cell culture
Sigma-Aldrich
Guanosine, ≥97.0% (HPLC)
Sigma-Aldrich
Cadmium chloride